cystic fibrosis	is a	genetic disorder
cystic fibrosis	is caused by	CFTR gene mutation
CFTR gene mutation	causes	CFTR dysfunction
CFTR gene mutation	leads to	reduced chloride transport
reduced chloride transport	causes	thick mucus
thick mucus	obstructs	airways
airway obstruction	reduces	gas exchange
gas exchange	declines with	cystic fibrosis progression
pancreatic insufficiency	leads to	malabsorption
malabsorption	causes	nutritional deficiency
cystic fibrosis	affects	exocrine glands
sweat chloride test	is used for	diagnosis of cystic fibrosis
newborn screening	may detect	cystic fibrosis
nasal potential difference test	assesses	CFTR function
CFTR modulators	treat	cystic fibrosis
ivacaftor	is a	CFTR potentiator
lumacaftor	is a	CFTR corrector
elexacaftor	is a	CFTR modulator
modulator therapy	improves	lung function in cystic fibrosis
triple therapy	is a	CFTR modulator combination
cystic fibrosis	predisposes to	chronic pulmonary infection
pseudomonas aeruginosa infection	is common in	cystic fibrosis
staphylococcus aureus infection	occurs in	cystic fibrosis
bronchiectasis	develops in	cystic fibrosis
airway colonization	precedes	chronic infection in cystic fibrosis
lung function	declines with	disease progression
pulmonary hypertension	complication of	cystic fibrosis
hemoptysis	complication of	cystic fibrosis
respiratory failure	can occur in	cystic fibrosis
cystic fibrosis-related diabetes	is a	complication of cystic fibrosis
fat-soluble vitamin deficiency	occurs in	cystic fibrosis
osteoporosis	common in	cystic fibrosis
bone density	reduced in	cystic fibrosis
pancreatic exocrine insufficiency	leads to	steatorrhea
fecal elastase	decreased in	pancreatic insufficiency
meconium ileus	presents in	cystic fibrosis
salty sweat	observed in	cystic fibrosis
paranasal sinus disease	common in	cystic fibrosis
nasal polyps	associated with	cystic fibrosis
digital clubbing	observed in	cystic fibrosis
exercise tolerance	reduced in	cystic fibrosis
osteopenia	occurs in	cystic fibrosis
nutrition therapy	improves	growth in cystic fibrosis
pancreatic enzyme replacement therapy	replaces	pancreatic enzymes
fat-soluble vitamins	supplementation improves	nutritional status in cystic fibrosis
inhaled antibiotics	used for	pulmonary infections in cystic fibrosis
oral antibiotics	used for	pulmonary infections in cystic fibrosis
inhaled mucolytics	improve	sputum clearance
airway clearance device	aids	mucus clearance
sputum culture	guides	antibiotic therapy
cystic fibrosis-related liver disease	occurs in	cystic fibrosis
liver fibrosis	associated with	cystic fibrosis
infection control measures	reduce	cross-infection risk in cystic fibrosis
lung function tests	monitor	disease progression in cystic fibrosis
spirometry	measures	lung function in cystic fibrosis
ct scan	evaluates	structural changes in cystic fibrosis
quality of life	affected by	cystic fibrosis
mortality	associated with	lung disease in cystic fibrosis
readmission risk	increased after	pulmonary exacerbation in cystic fibrosis
hospital admission	associated with	pulmonary exacerbation in cystic fibrosis
pulmonary exacerbation	triggers	hospitalization in cystic fibrosis
airway inflammation	present in	cystic fibrosis
neutrophils	release	elastase
elastase	causes	lung damage
airway remodeling	occurs in	advanced cystic fibrosis
infection control programs	improve	care outcomes in cystic fibrosis
genetic testing	confirms	CFTR mutation
F508del mutation	is a	common CFTR mutation
genotype	influences	phenotype in cystic fibrosis
lung clearance index	correlates with	disease severity in cystic fibrosis
clinic visits	predict	hospitalization in cystic fibrosis
home spirometry	enables	remote monitoring in cystic fibrosis
multidisciplinary team	improves	care in cystic fibrosis
psychological support	improves	quality of life in cystic fibrosis
airway clearance therapy	promotes	sputum clearance
neonatal screening	detects	cystic fibrosis
CFTR mutation	linked to	cystic fibrosis diagnosis
F508del mutation	is a	CFTR mutation
bile duct disease	observed in	cystic fibrosis
bone mineral density	reduced in	cystic fibrosis
diabetes mellitus	associated with	CFRD
meconium ileus	indicates	pancreatic involvement in cystic fibrosis
sodium chloride concentration in sweat	elevated in	cystic fibrosis
stool fat	increased in	pancreatic insufficiency in cystic fibrosis
growth failure	observed in	cystic fibrosis
bone metabolism	altered in	cystic fibrosis
antioxidant therapy	evaluated for	cystic fibrosis
airway infection	persistent in	cystic fibrosis
pseudomonas colonization	persistent in	cystic fibrosis
ciprofloxacin	used for	pseudomonas infection in cystic fibrosis
aztreonam	used for	pseudomonas infection in cystic fibrosis
lumacaftor-ivacaftor combination	approved for	CF with F508del mutation
pseudomonas infection	includes	antibiotic therapy in cystic fibrosis
mucus plugging	contributes to	airway obstruction
cystic fibrosis	affects	digestive tract
bile duct disease	associated with	cystic fibrosis
nasal discharge	present in	cystic fibrosis
clinical outcomes	improve with	comprehensive care in cystic fibrosis
quality of care	measured by	hospitalization rate in cystic fibrosis
research trials	accelerate	treatment options for cystic fibrosis
